In March, EMA released a concept paper outlining plans to revise
the Agency’s guidance covering the quality of water used for pharmaceutical
purposes. The revision takes into account the recent
decision by the European Pharmacopoeia to accept non-distillation
water technologies to produce water for injections (WFI).
Comments are due June 6.